[Quality of life in home-based cancer patients: A comparative study of chemotherapy administration route].
Identifieur interne : 000355 ( Main/Exploration ); précédent : 000354; suivant : 000356[Quality of life in home-based cancer patients: A comparative study of chemotherapy administration route].
Auteurs : Alice Dhellemmes [France] ; Claudine Melan [France] ; Florence Sordes [France]Source :
- Bulletin du cancer [ 1769-6917 ] ; 2019.
Descripteurs français
- KwdFr :
- Administration par voie orale (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Antinéoplasiques (administration et posologie), Antinéoplasiques (effets indésirables), Auto-efficacité (MeSH), Autosoins (MeSH), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Humains (MeSH), Injections veineuses (MeSH), Mâle (MeSH), Qualité de vie (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Tumeurs (psychologie), Tumeurs (traitement médicamenteux), Études transversales (MeSH).
- MESH :
- administration et posologie : Antinéoplasiques.
- effets indésirables : Antinéoplasiques.
- psychologie : Tumeurs.
- traitement médicamenteux : Tumeurs.
- Administration par voie orale, Adulte, Adulte d'âge moyen, Auto-efficacité, Autosoins, Enquêtes et questionnaires, Femelle, Humains, Injections veineuses, Mâle, Qualité de vie, Sujet âgé, Sujet âgé de 80 ans ou plus, Études transversales.
English descriptors
- KwdEn :
- Administration, Oral (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Antineoplastic Agents (administration & dosage), Antineoplastic Agents (adverse effects), Cross-Sectional Studies (MeSH), Female (MeSH), Humans (MeSH), Injections, Intravenous (MeSH), Male (MeSH), Middle Aged (MeSH), Neoplasms (drug therapy), Neoplasms (psychology), Quality of Life (MeSH), Self Care (MeSH), Self Efficacy (MeSH), Surveys and Questionnaires (MeSH).
- MESH :
- chemical , administration & dosage : Antineoplastic Agents.
- chemical , adverse effects : Antineoplastic Agents.
- drug therapy : Neoplasms.
- psychology : Neoplasms.
- Administration, Oral, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Injections, Intravenous, Male, Middle Aged, Quality of Life, Self Care, Self Efficacy, Surveys and Questionnaires.
Abstract
INTRODUCTION
Home healthcare can be totally different depending on the route of treatment: intravenous anticancer drugs involve regular contact with the health caregiver while the oral route leaves the patient completely autonomous. This cross-sectional research has a comparative purpose between the representations of disease and treatments, the self-efficacy and the quality of life of patients treated with oral anticancer drugs and those treated by intravenous route.
METHODS
The sample include 130 patients with cancer. Seventy-two are treated with intravenous chemotherapy and 48 by oral route. The protocol includes a questionnaire of disease representations (IPQ-r), treatment representations (BMQ), self-efficacy (GSES 10) and quality of life (QLQ-C30).
RESULTS
The administration route of anticancer treatment impacts the illness representations with the normalization of cancer. The intravenous route, by its invasive and time-consuming nature, increases difficulties in fulfilling family and professional roles. Moreover, side effects are correlated with the perceived dangerousness of the treatment and self-efficacy. Age and the length of time since the diagnosis affect respectively the understanding of the disease and the cognitive dimension of quality of life.
DISCUSSION
More than a difference in form of treatment, the whole pathway of healthcare has to be taken into account since it involves different psychological consequences, in particular about therapeutic choices or in terms of patient support.
DOI: 10.1016/j.bulcan.2019.09.009
PubMed: 31759513
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Quality of life in home-based cancer patients: A comparative study of chemotherapy administration route].</title><author><name sortKey="Dhellemmes, Alice" sort="Dhellemmes, Alice" uniqKey="Dhellemmes A" first="Alice" last="Dhellemmes">Alice Dhellemmes</name><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France. Electronic address: alicedhellemmes@gmail.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Melan, Claudine" sort="Melan, Claudine" uniqKey="Melan C" first="Claudine" last="Melan">Claudine Melan</name><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse, laboratoire CLLE; UMR 5263, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse, laboratoire CLLE; UMR 5263, 5, allée Antonio-Machado, 31058 Toulouse cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Sordes, Florence" sort="Sordes, Florence" uniqKey="Sordes F" first="Florence" last="Sordes">Florence Sordes</name><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31759513</idno><idno type="pmid">31759513</idno><idno type="doi">10.1016/j.bulcan.2019.09.009</idno><idno type="wicri:Area/Main/Corpus">000292</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000292</idno><idno type="wicri:Area/Main/Curation">000292</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000292</idno><idno type="wicri:Area/Main/Exploration">000292</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Quality of life in home-based cancer patients: A comparative study of chemotherapy administration route].</title><author><name sortKey="Dhellemmes, Alice" sort="Dhellemmes, Alice" uniqKey="Dhellemmes A" first="Alice" last="Dhellemmes">Alice Dhellemmes</name><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France. Electronic address: alicedhellemmes@gmail.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Melan, Claudine" sort="Melan, Claudine" uniqKey="Melan C" first="Claudine" last="Melan">Claudine Melan</name><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse, laboratoire CLLE; UMR 5263, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse, laboratoire CLLE; UMR 5263, 5, allée Antonio-Machado, 31058 Toulouse cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Sordes, Florence" sort="Sordes, Florence" uniqKey="Sordes F" first="Florence" last="Sordes">Florence Sordes</name><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author></analytic><series><title level="j">Bulletin du cancer</title><idno type="eISSN">1769-6917</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Antineoplastic Agents (administration & dosage)</term><term>Antineoplastic Agents (adverse effects)</term><term>Cross-Sectional Studies (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Injections, Intravenous (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Neoplasms (drug therapy)</term><term>Neoplasms (psychology)</term><term>Quality of Life (MeSH)</term><term>Self Care (MeSH)</term><term>Self Efficacy (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antinéoplasiques (administration et posologie)</term><term>Antinéoplasiques (effets indésirables)</term><term>Auto-efficacité (MeSH)</term><term>Autosoins (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Injections veineuses (MeSH)</term><term>Mâle (MeSH)</term><term>Qualité de vie (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Tumeurs (psychologie)</term><term>Tumeurs (traitement médicamenteux)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Injections, Intravenous</term><term>Male</term><term>Middle Aged</term><term>Quality of Life</term><term>Self Care</term><term>Self Efficacy</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie orale</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Auto-efficacité</term><term>Autosoins</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Injections veineuses</term><term>Mâle</term><term>Qualité de vie</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>Home healthcare can be totally different depending on the route of treatment: intravenous anticancer drugs involve regular contact with the health caregiver while the oral route leaves the patient completely autonomous. This cross-sectional research has a comparative purpose between the representations of disease and treatments, the self-efficacy and the quality of life of patients treated with oral anticancer drugs and those treated by intravenous route.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The sample include 130 patients with cancer. Seventy-two are treated with intravenous chemotherapy and 48 by oral route. The protocol includes a questionnaire of disease representations (IPQ-r), treatment representations (BMQ), self-efficacy (GSES 10) and quality of life (QLQ-C30).</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The administration route of anticancer treatment impacts the illness representations with the normalization of cancer. The intravenous route, by its invasive and time-consuming nature, increases difficulties in fulfilling family and professional roles. Moreover, side effects are correlated with the perceived dangerousness of the treatment and self-efficacy. Age and the length of time since the diagnosis affect respectively the understanding of the disease and the cognitive dimension of quality of life.</p></div><div type="abstract" xml:lang="en"><p><b>DISCUSSION</b></p><p>More than a difference in form of treatment, the whole pathway of healthcare has to be taken into account since it involves different psychological consequences, in particular about therapeutic choices or in terms of patient support.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31759513</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1769-6917</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Bulletin du cancer</Title><ISOAbbreviation>Bull Cancer</ISOAbbreviation></Journal><ArticleTitle>[Quality of life in home-based cancer patients: A comparative study of chemotherapy administration route].</ArticleTitle><Pagination><MedlinePgn>1124-1131</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0007-4551(19)30373-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bulcan.2019.09.009</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Home healthcare can be totally different depending on the route of treatment: intravenous anticancer drugs involve regular contact with the health caregiver while the oral route leaves the patient completely autonomous. This cross-sectional research has a comparative purpose between the representations of disease and treatments, the self-efficacy and the quality of life of patients treated with oral anticancer drugs and those treated by intravenous route.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The sample include 130 patients with cancer. Seventy-two are treated with intravenous chemotherapy and 48 by oral route. The protocol includes a questionnaire of disease representations (IPQ-r), treatment representations (BMQ), self-efficacy (GSES 10) and quality of life (QLQ-C30).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The administration route of anticancer treatment impacts the illness representations with the normalization of cancer. The intravenous route, by its invasive and time-consuming nature, increases difficulties in fulfilling family and professional roles. Moreover, side effects are correlated with the perceived dangerousness of the treatment and self-efficacy. Age and the length of time since the diagnosis affect respectively the understanding of the disease and the cognitive dimension of quality of life.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">More than a difference in form of treatment, the whole pathway of healthcare has to be taken into account since it involves different psychological consequences, in particular about therapeutic choices or in terms of patient support.</AbstractText><CopyrightInformation>Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dhellemmes</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France. Electronic address: alicedhellemmes@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melan</LastName><ForeName>Claudine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Université de Toulouse, laboratoire CLLE; UMR 5263, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sordes</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Université de Toulouse, laboratoire CERPPS, Pôle 3: psychologie de la santé, EA7411, 5, allée Antonio-Machado, 31058 Toulouse cedex 9, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Qualité de vie des patients atteints de cancer traités à domicile : étude comparative des différentes voies d’administration de la chimiothérapie.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Bull Cancer</MedlineTA><NlmUniqueID>0072416</NlmUniqueID><ISSNLinking>0007-4551</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020377" MajorTopicYN="Y">Self Efficacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anticancéreux oraux</Keyword><Keyword MajorTopicYN="N">Illness representations</Keyword><Keyword MajorTopicYN="N">Oral anticancer treatment</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Qualité de vie</Keyword><Keyword MajorTopicYN="N">Représentations de la maladie</Keyword><Keyword MajorTopicYN="N">Représentations des traitement</Keyword><Keyword MajorTopicYN="N">Self-efficacy</Keyword><Keyword MajorTopicYN="N">Sentiment d’auto-efficacité</Keyword><Keyword MajorTopicYN="N">Treatment representations</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31759513</ArticleId><ArticleId IdType="pii">S0007-4551(19)30373-X</ArticleId><ArticleId IdType="doi">10.1016/j.bulcan.2019.09.009</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Midi-Pyrénées</li><li>Occitanie (région administrative)</li></region><settlement><li>Toulouse</li></settlement></list><tree><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Dhellemmes, Alice" sort="Dhellemmes, Alice" uniqKey="Dhellemmes A" first="Alice" last="Dhellemmes">Alice Dhellemmes</name></region><name sortKey="Melan, Claudine" sort="Melan, Claudine" uniqKey="Melan C" first="Claudine" last="Melan">Claudine Melan</name><name sortKey="Sordes, Florence" sort="Sordes, Florence" uniqKey="Sordes F" first="Florence" last="Sordes">Florence Sordes</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000355 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000355 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:31759513
|texte= [Quality of life in home-based cancer patients: A comparative study of chemotherapy administration route].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31759513" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |